A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives

A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives

The discovery of Epidermal Growth Factor Receptor (EGFR) mutations in Non Small Cell Lung Cancer (NSCLC) launched the era of personalized medicine in advanced NSCLC, leading to a dramatic shift in the therapeutic landscape of this disease. After ten years from the individuation of activating mutatio...

Full description

Bibliographic Details
Main Authors: Russo, Alessandro, Franchina, Tindara, Rita Ricciardi, Giuseppina Rosaria, Picone, Antonio, Ferraro, Giuseppa, Zanghì, Mariangela, Toscano, Giuseppe, Giordano, Antonio, Adamo, Vincenzo
Format: Online
Language:English
Published: Impact Journals LLC 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694955/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694955/

Similar Items